Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
GlobalGiving - Teaching Note
Anik, Lalin; Steenburgh, Thomas J.Nota del Instructor DARDEN-M-0938TN-EMarketingTeaching note for product M-0938Desde 0,00 €
-
BP in Russia: Bad Partners or Bad Partnerships? (A) and (B) - Teaching Note
Spekman, Robert E.; Linetsky, ZuriNota del Instructor DARDEN-M-0819TN-EMarketingTeaching note for product M-0819Desde 0,00 €
-
Pricing the EpiPen: This is Going to Sting - Teaching Note
Steenburgh, Thomas J.Nota del Instructor DARDEN-M-0915TN-EMarketingTeaching note for product M-0915Desde 0,00 €
-
Progressive Insurance: Making Pay As You Drive a Snap for Consumers - Teaching Note
Farris, Paul W.; Steenburgh, Thomas J.; Maiden, Stephen E.Nota del Instructor DARDEN-M-0873TN-EMarketingTeaching note for product M-0873Desde 0,00 €
-
Progressive Insurance: Making Pay As You Drive a Snap for Consumers
Farris, Paul W.; Thompson, Sylvie; Steenburgh, Thomas J.Caso DARDEN-M-0873-EMarketingHeather Day, a marketing director and brand manager, must evaluate her options for Progressive Insurance’s next Snapshot product advertising campaign. Working on a limited budget, Day must select between employing television ads featuring the popular character known as Flo and continuing with the launch of advertising campaigns already in use, such as “Rate Sucker.” The case places Progressive’s proposed advertising campaign into a broader histor...Desde 8,20 €
-
BP in Russia: Bad Partners or Bad Partnerships? (A)
Spekman, Robert E.; Linetsky, ZuriCaso DARDEN-M-0819-EMarketingThis case pairing is used in Darden's "Business to Business Marketing" course elective. Following the Deepwater Horizon oil spill, BP seeks to expand its assets and revenues, so it looks to Russia, but a planned alliance with a Russian state-owned oil company is thwarted by objections from another Russian oil partner. This case maps BP's strategic alliances and illustrates the importance of alliance management. This is the first part of a two-par...Desde 8,20 €
-
Mastercard: Getting in League with Legends
Kim, Tami; Steenburgh, Thomas J.; Yemen, GerryCaso DARDEN-M-1008-EMarketingThis field-based case uses one of Mastercard’s brand transformation strategies, curating passion-led experiences, to set the stage for analysis of sponsorships and promotion marketing. The company had a long relationship sponsoring sports and kept track of the growth and scale of various sports and those who were passionate about them. At the time, esports was a new kind of entertainment and sport that attracted a fan base Mastercard had not touc...Desde 8,20 €
-
BP in Russia: Bad Partners or Bad Partnerships? (B)
Spekman, Robert E.; Linetsky, ZuriCaso DARDEN-M-0845-EMarketingThis second part of a two-part case provides the epilogue to the story of BP's conflicts with Russian oil partners and underscores the importance of alliance management.Desde 5,74 €
-
GlobalGiving
Anik, Lalin; Steenburgh, Thomas J.; Steenburgh, LauraCaso DARDEN-M-0938-EMarketingNonprofits are facing a growing challenge to retain donors. At a time when acquiring a new donor is three times as expensive as retaining an existing donor and donor attrition stands at an all-time high, nonprofits are looking to increase the lifetime value of their donors. This case presents a new means by which nonprofits can induce donors to give today and commit to giving in the future. The positive results of a low-cost, high-yield experimen...Desde 8,20 €
-
Pricing the EpiPen: This is Going to Sting
Steenburgh, Thomas J.Caso DARDEN-M-0915-EMarketingThis case examines the public controversy that erupted over the increasingly high price of EpiPens. Mylan Inc. (Mylan), a generic drug maker, bought the EpiPen product line from Merck in 2007. Since that time, the company both invested in marketing to raise awareness for the drug and dramatically increased the price, lifting it from $100 to $600 per two pack in the U.S. In 2016, simmering consumer anger about the high prices of pharmaceutical dru...Desde 8,20 €